Insulin Degludec 73070-0503-15

Package NDC

73070-0503-15

Manufacturer: Novo Nordisk Pharma, Inc.
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: July 1, 2022
Listing Expires: December 31, 2026
Application: BLA203314

Need to source Insulin Degludec? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Insulin Degludec	200 U/mL

Drug Class

Insulin Analog [EPC]Insulin Analog [EPC]Insulin [CS]

Selected Package

73070-0503-15Selected

3 SYRINGE, PLASTIC in 1 CARTON (73070-503-15) / 3 mL in 1 SYRINGE, PLASTIC